Answers are grounded in this paper and cite their sources.
Long COVID-19-related dysautonomia is associated with persistent cognitive and visual complaints, but brief clinically feasible tools for characterizing visual-attentional performance are needed. In this case-control study, 48 individuals with long COVID-19-related dysautonomia and 30 healthy controls completed the Modified Adult Developmental Eye Movement Test (ADEM-d), a timed visual-verbal reading/scanning task that requires sequential saccadic deployment, and the Continuous Visual Attention Test (CVAT). Compared with controls, the study group showed longer adjusted horizontal (median 73.63 vs. 54.69 s), vertical (66.35 vs. 50.66 s), and distractor (83.97 vs. 64.55 s) reading times (all Holm-adjusted p < 0.001; rank-biserial r = 0.58–0.60), whereas the horizontal/vertical ratio did not differ significantly ( p = 0.108). On the CVAT, the study group showed longer reaction time (378.5 vs. 320.0 ms; Holm-adjusted p < 0.001), greater reaction-time variability (96.0 vs. 62.5 ms; p = 0.001), and more omission errors ( p = 0.028). Across the full sample, distractor-condition ADEM-d time was positively associated with omission errors, reaction time, and reaction-time variability (Spearman rho = 0.55–0.58; all p < 0.001). These findings indicate altered functional visual-verbal scanning and visual-attentional performance in this cohort. Because the ADEM-d does not directly record eye movements, the results do not demonstrate a primary saccadic motor deficit; additionally, the absence of a long-COVID group without dysautonomia prevents attribution of the findings specifically to dysautonomia. The ADEM-d and CVAT may nevertheless provide brief screening information to identify individuals who require more detailed visual, oculomotor, or neuropsychological assessment.
No takes yet. Share an insight, caveat, or question.
González-Vides et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: